Median (IQR) or n (%) | Reference range | |
---|---|---|
Age, yrs | 70 (59–79) | |
Female sex | 219 (45.0) | |
Cancer site | ||
Gastrointestinal tract | 127 (26.1) | |
Hepatobiliary/pancreatic | 118 (24.2) | |
Lung | 108 (22.2) | |
Urogenital tract | 57 (11.7) | |
Others | 77 (15.8) | |
ECOG-PS | ||
≤ 2 | 115 (23.6) | |
3 | 189 (38.8) | |
4 | 183 (37.6) | |
Active infectiona | 164 (33.7) | |
Laboratory parameter | ||
White blood cells, 103/mm3 | 9.1 (6.3–12.7) | 3.8–10 |
Neutrophils, % | 78.9 (72.0–85.7) | 50–75 |
Lymphocytes, % | 11.2 (6.8–17.4) | 20–44 |
Hemoglobin, g/dL | 10.1 (8.8–11.7) | 13–17 |
Platelets, 103/mm3 | 227 (154–323) | 150–400 |
Creatinine, mg/dL | 0.8 (0.5–1.2) | 0.5–1.2 |
Albumin, g/dL | 3.2 (2.8–3.7) | 3.5–5.2 |
Total bilirubin, mg/dL | 0.7 (0.5–1.4) | 0.2–1.2 |
PT/INR | 1.2 (1.1–1.3) | 0.8–1.2 |
C-reactive protein, mg/dL | 5.2 (2.3–12.9) | 0–0.5 |
Sodium, mEq/L | 134 (130–137) | 135–145 |
Potassium, mEq/L | 4.2 (3.8–4.6) | 3.5–5.5 |
Censoredb | 19 (3.9) | |
Survival time, days | 26 (14–45) |